Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
LabCorp grabs Medtox for $241M
Tue, 06/5/12 - 10:37 pm
LabCorp
Medtox
M&A
Amylin Said To Draw Bids Of $25 To $29 A Share In First Round
Bloomberg
Tue, 06/5/12 - 09:39 am
Amylin
M&A
Sanofi
AstraZeneca
Merck
Bristol-Myers Squibb
Bad Romance: Glaxo's Brutal Courtship of Human Genome Sciences
TheStreet.com
Mon, 06/4/12 - 10:53 am
GSK
M&A
Human Genome Sciences
Is Sun Pharma getting back on the acquisition track?
Live Mint
Sun, 06/3/12 - 01:47 pm
Sun Pharma
M&A
AstraZeneca bids $4bn for diabetes specialist Amylin
Telegraph, UK
Sun, 06/3/12 - 01:45 pm
AstraZeneca
Amylin
M&A
Bristol, AstraZeneca among Amylin bidders-sources
Interactive Investor
Sun, 06/3/12 - 12:23 pm
Bristol-Myers Squibb
AstraZeneca
Amylin
M&A
Merck has no plans to sell animal and consumer health businesses
NJ.com
Fri, 06/1/12 - 10:32 am
Merck
animal health
M&A
OTC
Forest Laboratories and Nabriva Therapeutics Sign Agreement
Yahoo
Fri, 06/1/12 - 10:28 am
Forest Labs
Nabriva Therapeutics
BC-3781
M&A
Human Genome Sciences Takeover Defense Survives Court Test
Bloomberg
Thu, 05/31/12 - 06:13 pm
Human Genome Sciences
GSK
M&A
hostile bid
The Race For Amylin Kicks Into High-Gear
Seeking Alpha
Wed, 05/30/12 - 03:01 pm
Amylin
M&A
AstraZeneca
Bristol-Myers Squibb
Pfizer
Exclusive: GSK eyes replacing Human Genome board: sources
Reuters
Wed, 05/30/12 - 10:29 am
GSK
Human Genome Sciences
M&A
hostile bid
Who Should Buy Amylin?
Motley Fool
Tue, 05/29/12 - 04:44 pm
M&A
Amylin
Sanofi
Merck
Bristol-Myers Squibb
Takeda
AstraZeneca
Human Genome shareholder sues board over GSK "poison pill," Reuters reports
Yahoo/Fly on the Wall
Tue, 05/29/12 - 11:11 am
Human Genome Sciences
GSK
poison pill
M&A
Human Genome Shareholders Should Not Get Greedy
Seeking Alpha
Mon, 05/28/12 - 11:11 am
GSK
M&A
Human Genome Sciences
Reports: Sanofi, Merck Bid At Least $25 Per Share For Amylin
Barron's
Mon, 05/28/12 - 11:11 am
Merck
Sanofi
Amylin
M&A
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover
Bloomberg
Fri, 05/25/12 - 11:16 am
GSK
diabetes
M&A
albiglutide
Human Genome Sciences
Takeda chases emerging market sales with Brazil buy
Reuters
Fri, 05/25/12 - 09:57 am
Takeda
M&A
Brazil
Multilab
Glaxo Avoids Market For Lemons By Buying Collaborators
Bloomberg
Thu, 05/24/12 - 10:27 am
GSK
M&A
Human Genome Sciences
Theravance
diaDexus
iTech Medical Announces Acquisition of BioFlex Medical Magnetics
Wed, 05/23/12 - 10:51 pm
iTech Medical
M&A
BioFlex Medical Magnetics
GSK to drop Human Genome bid if "poison pill" stands
Yahoo/Reuters
Wed, 05/23/12 - 12:09 pm
Human Genome Sciences
GSK
M&A
poison pill
Pages
« first
‹ previous
…
240
241
242
243
244
245
246
247
248
…
next ›
last »